GE HealthCare Technologies (GEHC) Earnings
Price: $68.09
Market Cap: $31.17B
Market Cap: $31.17B
Revenue (TTM): $19.67B
Net Income: $1.99B
Net Income: $1.99B
P/E Ratio: 15.61
EPS (TTM): $4.36
EPS (TTM): $4.36
Earnings Dates
GE HealthCare Technologies (GEHC) reports its earnings quarterly. Here are the key details:
Next Earnings Date
- Date: April 30, 2025
- Time of Day: Before Market Open
- Estimated EPS: $0.91
Last Earnings Report
- Date: February 13, 2025
- EPS: $1.45
- EPS Estimate: $1.26
GE HealthCare Technologies's next earnings report is scheduled for April 30, 2025.
In its last earnings report on February 13, 2025, GE HealthCare Technologies reported earnings per share (EPS) of $1.45, compared to an estimated EPS of $1.26. The company reported revenue of $5.32B, compared to an estimated revenue of $5.33B.
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-13 | $1.26 | $1.45 |
| Read Transcript | Q3 | 2024 | 2024-10-30 | $1.05 | $1.14 |
| Read Transcript | Q2 | 2024 | 2024-07-31 | $0.98 | $1.00 |
| Read Transcript | Q1 | 2024 | 2024-04-30 | $0.91 | $0.90 |
| Read Transcript | Q4 | 2023 | 2024-02-06 | $1.07 | $1.18 |
| Read Transcript | Q3 | 2023 | 2023-11-03 | N/A | N/A |
| Read Transcript | Q2 | 2023 | 2023-07-25 | $0.87 | $0.92 |
| Read Transcript | Q1 | 2023 | 2023-04-25 | $0.79 | $0.85 |
| Read Transcript | Q4 | 2022 | 2023-02-01 | N/A | N/A |
Earnings History
| Date | EPS | EPS Estimate | Revenue | Revenue Estimate |
|---|---|---|---|---|
| February 13, 2025 | $1.45 | $1.26 | $5.32B | $5.33B |
| October 30, 2024 | $1.14 | $1.05 | $4.86B | $4.87B |
| July 31, 2024 | $1.00 | $0.98 | $4.84B | $4.88B |
| April 30, 2024 | $0.90 | $0.91 | $4.65B | $4.80B |
| February 06, 2024 | $1.18 | $1.07 | $5.21B | $5.09B |
| October 31, 2023 | $0.99 | $0.90 | $4.82B | $4.80B |
| July 25, 2023 | $0.92 | $0.87 | $4.82B | $4.79B |
| April 25, 2023 | $0.85 | $0.79 | $4.71B | $4.63B |
| January 30, 2023 | $1.31 | $ | $4.94B | $4.90B |
| December 08, 2022 | $1.07 | $ | $4.48B | $- |
| September 30, 2022 | $1.07 | $ | $4.58B | $- |
| March 31, 2022 | $0.86 | $ | $4.34B | $- |
| December 31, 2021 | $1.24 | $ | $4.59B | $- |
| September 29, 2021 | $1.11 | $ | $4.30B | $- |
| June 29, 2021 | $1.28 | $ | $4.35B | $- |
| March 30, 2021 | $1.28 | $ | $4.35B | $- |
Annual Earnings
Annual Revenue
$19.67B
Fiscal Year 2024Annual Net Income
$1.99B
Fiscal Year 2024Annual EPS
$4.37
Fiscal Year 2024Quarterly Earnings
Revenue
$5.32B
Quarter Ending December 31, 2024Net Income
$720.00M
Quarter Ending December 31, 2024EPS
$1.58
Quarter Ending December 31, 2024Earnings Metrics
Earnings Yield
5.59%
Year Ending December 31, 2024P/E Ratio
17.89
Year Ending December 31, 2024Revenue Per Share
$43.14
Year Ending December 31, 2024Earnings Yield (TTM)
6.40%
Trailing Twelve MonthsP/E Ratio (TTM)
15.61
Trailing Twelve MonthsRevenue Per Share (TTM)
$43.04
Trailing Twelve MonthsFrequently Asked Questions
GE HealthCare Technologies's next earnings date is scheduled for April 30, 2025. The earnings call is expected to take place before market open.
In its last earnings report on February 13, 2025, GE HealthCare Technologies reported earnings per share (EPS) of $1.45, compared to an estimated EPS of $1.26. The company reported revenue of $5.32B, compared to an estimated revenue of $5.33B.
GE HealthCare Technologies's current Price-to-Earnings (P/E) ratio is 17.89. The trailing twelve months (TTM) P/E ratio is 15.61. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.
For the fiscal year ending December 31, 2024, GE HealthCare Technologies reported total revenue of $19.67B and net income of $1.99B. This represents a net profit margin of 0.1013115087.
GE HealthCare Technologies's earnings yield is 5.59%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.
GE HealthCare Technologies's return on equity (ROE) is 23.60%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.
GE HealthCare Technologies's gross profit margin is 41.71%. This indicates that for every dollar of revenue, the company retains $0.42 as gross profit after accounting for the cost of goods sold.